Risk Adjusted Net Present Value: What is the current valuation of Iovance Biotherapeutics’s Lifileucel

Long COVID in the U.S. is rare among children and has affected roughly one in 14 adults, according to a pair of data briefs from

Hyperbaric oxygen therapy (HBOT) was not effective for reducing pain, but was effective for reducing fibrosis, among women with late local toxic effects after irradiation

Anti-tumor necrosis factor (TNF) therapy for new-onset inflammatory bowel disease (IBD) was independently associated with progressive kidney function decline but not survival, a VA cohort